Reversal of multidrug resistance by "Changweiqing" on vincristine-resistant human colorectal cancer cell line HCT8/V

Tumor

Volumn 28, Issue 9, 2008, Pages

  Deng, Wan Li ^a   Xu, Jian Hua ^a   Li, Chang Long ^b   Sun, Jue ^a   Zhang, Yong ^a   Fan, Zhong Ze ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antineoplastic drugs(TCD); Colorectal neoplasms; Drug resistance, multiple; Serum; Tumor cells, cultured

Indexed keywords

CAMPTOTHECIN DERIVATIVE; CHANGWEIQING; CHINESE DRUG; CISPLATIN; FLUOROURACIL; HYDROXYCAMPTOTHECIN; MITOMYCIN C; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL ASSAY; CELL LEVEL; COLORECTAL CANCER; CONTROLLED STUDY; CROSS RESISTANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; MULTIDRUG RESISTANCE;

EID: 77953370524     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2008.09.009     Document Type: Article

References (6)

1. Chinese source.
2. Chinese source.
3. TAKARA K, SAKAEDA T, OKUMURA K. An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy [J]. Curt Pharm Des,2006,12(3):273-286.
4. BECK W T. The cell biology of multiple drug resistance[J]. Biochem Pharmacol,1987,36(18):2879-2887.
5. Chinese source.
6. Chinese source.